ASCO 2016

June 13, 2016June 13, 2016

Mogamulizumab More Effective Than Chemotherapy for Adult T-Cell Leukemia-Lymphoma, Study Finds

News

Results from a Phase 2 clinical trial demonstrate that the drug mogamulizumab promotes better response rates than standard chemotherapy in patients with a rare form of cancer, called relapsed of refractory adult T-cell leukemia-lymphoma ... Read more

June 9, 2016June 9, 2016

Pedriatric Hodgkin Lymphoma Patients Who Gain Body Fat During Treatment May Be at Higher Risk of Relapsing

News

Increase in body fat in pediatric Hodgkin lymphoma patients may be linked to disease relapse, according to the study “Visceral fat and muscle changes during 6-week chemotherapy in pediatric Hodgkin ... Read more

June 8, 2016June 8, 2016

ASCO 2016 – AbbVie’s Imbruvica Phase 3 Trials in Leukemia and Lymphoma Patients Show Long-Term Favorable Responses

News

AbbVie has just presented long-term data on Imbruvica (ibrutinib) effects in patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), revealing its therapeutic potential in these diseases. The ... Read more